Traduction de «point d'attente de circulation » (Français → Anglais) :

The issues identified in the Commission report refer inter alia to: complex rules and conditions for short and long term stays in Russia; lengthy waiting time at some of the border crossing points between Russia and the EU; the current extremely centralised system of law enforcement and judicial cooperation in Russia which delays considerably the reception of Russian replies; adequate data protection in Russia which would enable the conclusion of cooperation agreements with Europol and Eurojust; lack of a comprehensive system to t ...[+++]ackle trafficking in human beings including addressing the needs of its victims, Russia’s liberal system of the change of the name and the anti-corruption policy are issues of importance for EU-Russia Visa Dialogue which, if not tackled properly, may undermine the efforts done so far; in addition further efforts on a comprehensive policy towards fighting the discrimination and xenophobia are essential to ensure a safe and predictable environment underpinning the freedom of movement.

The concept of the flexible use of airspace should be applied effectively; it is necessary to optimise the use of sectors of airspace, especially during peak periods for general air traffic and in high-traffic airspace, by cooperation between Member States in respect of the use of such sectors for military operations and training.

(14) The concept of the flexible use of airspace should be applied effectively; it is necessary to optimise the use of sectors of airspace, especially during peak periods for general air traffic and in high-traffic airspace, by cooperation between Member States in respect of the use of such sectors for military operations and training.

- MEDICINAL PLANT PREPARATIONS "THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, Whereas, in its Resolution of 30 November 1995 on the integration of health protection requirements in Community policies, the Council considers that the Community must pay particular attention to the impact on health of action proposed in a number of areas, including free movement of goods; Whereas action to improve understanding of and address the effects on human health of the free movement of goods, ...[+++]in particular the free movement of medicinal products, should form part of the Community's overall strategy for action in the field of public health; Considering the wider use of medicinal plants in medical treatment in the European Union; Considering the growing use of medicinal plants in the European Union; Considering the impact of medicinal plant preparations on public health and the recommendations of the World Health Organization; Considering the heterogeneity of the commercial presentation of those preparations on the market; Whereas the safeguarding of public health must be a priority objective at Community level; Whereas it is also necessary to pay appropriate attention to conditions which will ensure that the development of industry and the free movement of such products within the European Union are not hindered; Considering the specific problems involved in checking raw materials and medicinal plant preparations from third countries in order to guarantee their quality; Whereas it is appropriate to take into account the special characteristics of such preparations; Whereas it is necessary to guarantee the protection of consumers' health throughout the whole process of manufacture, distribution and putting up for sale, CALLS ON the Commission, in close cooperation with the Member States, to study the situation that exists and, in particular: - whether there are public health concerns over medicinal plant preparations ...

- MUTUAL RECOGNITION OF THE VALIDITY OF MEDICAL PRESCRIPTIONS IN THE MEMBER STATES "THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, Whereas, in its Resolution of 30 November 1995 on the integration of health protection requirements in Community policies, the Council considers that the Community must pay particular attention to the impact on health of action proposed in a number of areas, including free movement of goods; Whereas action to improve understanding of and address the impact on human health of the free movement of goods, in particular the free movement of medicinal products, ...[+++] should form part of the Community's overall strategy for action in the field of public health; Whereas the internal market comprises an area without internal frontiers in which the free movement of goods, persons, services and capital is ensured; Whereas patients, in moving from one Member State to another, could in practice be prevented from purchasing medicinal products prescribed by an authorized medical practitioner in another Member State; Whereas, pursuant to the Treaty and to Directive 93/16/EEC, all discriminatory treatment based on nationality with regard to establishment and provision of services is prohibited in medical practice; Whereas this Resolution does not affect provisions governing the financing or reimbursement of the cost of medicinal products by national social security schemes; Whereas, moreover, this Resolution does not cover prescriptions for a non-exempt dose of a substance classified as a narcotic drug or psychotropic substance under United Nations international conventions, CALLS on the Commission, in cooperation with the Member States and taking account of work in this area by the relevant international organizations, to look into the present position with regard to the mutual recognition of medical prescriptions in the Member States.

As regards mass-risks, our attention must focus on two particular matters, identified by the Court in its rulings in 1986, in order to secure freedom of services based in large measure on home country control. These are: a) the financial soundness of companies, and b) contract law and conditions.